(NASDAQ:SSII), FORT LAUDERDALE, Fla., Nov. 06, 2025 (GLOBE NEWSWIRE) — SS Innovations International, Inc. (the “Company” or “SS Innovations”) (Nasdaq: SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and accessible to a global population, today announced the successful completion of the first telesurgery performed with the Company's SSi Mantra […]

(NASDAQ:AENT), PLANTATION, Fla., Nov. 06, 2025 (GLOBE NEWSWIRE) — Alliance Entertainment Holding Corporation (Nasdaq: AENT), a premier distributor and omnichannel fulfillment partner to the entertainment and pop culture collectibles industry, supplying more than 340,000 unique SKUs across music, video, video games, licensed merchandise, and exclusive collectibles to over 35,000 retail and e-commerce storefronts, today announced

(NASDAQ:WTF), HONG KONG, Nov. 06, 2025 (GLOBE NEWSWIRE) — Waton Financial Limited (NASDAQ: WTF), a provider of securities brokerage and financial technology services (“Waton” or the “Company”), today announced the delivery of a tokenized AI agent to MOG Digitech Holdings Limited (“MOG Digitech”) (HKEX: 1942) to serve as its AI investor relations officer, developed using

(NASDAQ:IMA), SAN DIEGO, Nov. 06, 2025 (GLOBE NEWSWIRE) — ImageneBio, Inc. (Nasdaq: IMA, “Imagene,” “Company”), a clinical-stage biotechnology company developing therapeutics for patients with immunological, autoimmune and inflammatory diseases, including IMG-007, an anti-OX40 monoclonal antibody with multiple differentiating features, today announced management participation in fourth quarter investor conferences. 2025 Stifel Healthcare ConferenceFireside Chat: Thursday, November

(Other OTC:RDGL),(OTC US:RDGL), Kennewick, WA, Nov. 06, 2025 (GLOBE NEWSWIRE) — Vivos Inc. (OTCQB: RDGL) – The Company continues to prioritize securing FDA Investigational Device Exemption (IDE) approval to initiate human clinical studies at Mayo Clinic. Over the past several years, Vivos has successfully responded to inquiries from more than 40 unique FDA reviewers. Many

(NASDAQ:SNAL), CULVER CITY, Calif., Nov. 06, 2025 (GLOBE NEWSWIRE) — Snail, Inc. (Nasdaq: SNAL) (“Snail Games” or the “Company”), a leading global independent developer and publisher of interactive digital entertainment, continues to demonstrate steady growth across its entertainment portfolio through new content launches and industry recognition. Recent milestones highlight the progression of Snail's diversified business

(CNSX:ACT.CN),(OTC US:ACTHF),(Other OTC:ACTHF),(Boerse Frankfurt – Freiverkehr:9D5),(NASDAQ:ADUR), LONDON, Ontario, Nov. 06, 2025 (GLOBE NEWSWIRE) — Aduro Clean Technologies Inc. (“Aduro” or the “Company“) (Nasdaq: ADUR) (CSE: ACT) (FSE: 9D5), a clean technology company using the power of chemistry to transform lower value feedstocks, like waste plastics, heavy bitumen, and renewable oils, into resources for the 21st

(NASDAQ:PODC), LOS ANGELES, Nov. 06, 2025 (GLOBE NEWSWIRE) — PodcastOne (Nasdaq: PODC), a leading publisher and podcast sales network, announced today that it will be hosting a conference call to discuss its operating and financial results for the second fiscal quarter ended September 30, 2025 (“Q2 Fiscal 2026”) on Tuesday, November 11, 2025. PodcastOne President,

(Other OTC:WNLV),(OTC US:WNLV), RENO, NV, Nov. 06, 2025 (GLOBE NEWSWIRE) — Winvest Group (OTCQB: WNLV), a U.S.-listed investment holding company with portfolios spanning media, entertainment, and technology, today announced a strategic partnership with the Greater Bay Area RWA Incubator. This collaboration is designed to advance the real-world asset (RWA) ecosystem across Southeast Asia, with the

(NASDAQ:MYGN), SALT LAKE CITY, Nov. 06, 2025 (GLOBE NEWSWIRE) — Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, announced it will share 11 new research studies highlighting advancements in oncology and reproductive genetic testing at the National Society of Genetic Counselors (NSGC) 44th Annual Conference. Myriad's MyRisk(R) Hereditary Cancer